Trials / Completed
CompletedNCT00940797
Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP)
Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients by Glucose CLAMP Technique
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Laboratorios Silanes S.A. de C.V. · Industry
- Sex
- All
- Age
- 40 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to determine the effect of DMMET-01 on insulin sensitivity by Glucose CLAMP technique in Mexican type 2 diabetes patients, after 2 months of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DMMET-01 | 60 days: 30 days; dose 1050.6 mg per day (before dinner)+ 30 days; dose 1050.6 mg twice a day 30 more days (before breakfast ando before dinner) |
| DRUG | Placebo | 60 days: 30 days placebo once a day (before dinner) + 30 days twice a day (before breakfast and before dinner) |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2009-02-01
- First posted
- 2009-07-16
- Last updated
- 2009-07-16
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT00940797. Inclusion in this directory is not an endorsement.